Myasthenia Gravis Treatment Market Size, Share & Trends Analysis Report By Type (Ocular MG, Congenital MG, Transient Neonatal MG), By Treatment (Medication, Surgery, Autologous Hematopoietic Stem Cell Transplantation (HSCT), Plasmapheresis and Intravenous Immunoglobulin, Others), By End-User (Hospitals, Clinics, Academic Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 04, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Myasthenia Gravis Treatment Market Size Analysis
    1. Introduction
    2. Myasthenia Gravis Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Ocular MG 
      2. Congenital MG 
      3. Transient Neonatal MG
    3. Myasthenia Gravis Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Medication 
      2. Surgery 
      3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
      4. Plasmapheresis and Intravenous Immunoglobulin 
      5. Others
    4. Myasthenia Gravis Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals 
      2. Clinics 
      3. Academic Research Institutes 
      4. Others
  7. North America Myasthenia Gravis Treatment Market Size Analysis
    1. Introduction
    2. Myasthenia Gravis Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Ocular MG 
      2. Congenital MG 
      3. Transient Neonatal MG
    3. Myasthenia Gravis Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Medication 
      2. Surgery 
      3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
      4. Plasmapheresis and Intravenous Immunoglobulin 
      5. Others
    4. Myasthenia Gravis Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals 
      2. Clinics 
      3. Academic Research Institutes 
      4. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
  8. Europe Myasthenia Gravis Treatment Market Size Analysis
    1. Introduction
    2. Myasthenia Gravis Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Ocular MG 
      2. Congenital MG 
      3. Transient Neonatal MG
    3. Myasthenia Gravis Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Medication 
      2. Surgery 
      3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
      4. Plasmapheresis and Intravenous Immunoglobulin 
      5. Others
    4. Myasthenia Gravis Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals 
      2. Clinics 
      3. Academic Research Institutes 
      4. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
  9. APAC Myasthenia Gravis Treatment Market Size Analysis
    1. Introduction
    2. Myasthenia Gravis Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Ocular MG 
      2. Congenital MG 
      3. Transient Neonatal MG
    3. Myasthenia Gravis Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Medication 
      2. Surgery 
      3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
      4. Plasmapheresis and Intravenous Immunoglobulin 
      5. Others
    4. Myasthenia Gravis Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals 
      2. Clinics 
      3. Academic Research Institutes 
      4. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
  10. Middle East and Africa Myasthenia Gravis Treatment Market Size Analysis
    1. Introduction
    2. Myasthenia Gravis Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Ocular MG 
      2. Congenital MG 
      3. Transient Neonatal MG
    3. Myasthenia Gravis Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Medication 
      2. Surgery 
      3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
      4. Plasmapheresis and Intravenous Immunoglobulin 
      5. Others
    4. Myasthenia Gravis Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals 
      2. Clinics 
      3. Academic Research Institutes 
      4. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
  11. LATAM Myasthenia Gravis Treatment Market Size Analysis
    1. Introduction
    2. Myasthenia Gravis Treatment Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Ocular MG 
      2. Congenital MG 
      3. Transient Neonatal MG
    3. Myasthenia Gravis Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Medication 
      2. Surgery 
      3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
      4. Plasmapheresis and Intravenous Immunoglobulin 
      5. Others
    4. Myasthenia Gravis Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals 
      2. Clinics 
      3. Academic Research Institutes 
      4. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Ocular MG 
        2. Congenital MG 
        3. Transient Neonatal MG
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Medication 
        2. Surgery 
        3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
        4. Plasmapheresis and Intravenous Immunoglobulin 
        5. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Academic Research Institutes 
        4. Others
  12. Competitive Landscape
    1. Myasthenia Gravis Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Valeant Pharmaceuticals International
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis Pharmaceuticals Corporation
    3. Apotex Corporation
    4. Teva Pharmaceutical Industries Ltd.
    5. RPG Life Sciences
    6. Cipla
    7. F. Hoffmann Roche La Ltd.
    8. Bristol-Myers Squibb Company
    9. Biogen Inc.
    10. AbbVie Inc.
    11. GlaxoSmithKline plc
    12. Fresenius Kabi
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Myasthenia Gravis Treatment Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 3: Global Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 4: Global Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 5: North America Myasthenia Gravis Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 7: North America Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 8: North America Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 9: U.S. Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 10: U.S. Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 11: U.S. Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 12: Canada Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 13: Canada Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 14: Canada Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 15: Europe Myasthenia Gravis Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 17: Europe Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 18: Europe Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 19: U.K. Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 20: U.K. Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 21: U.K. Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 22: Germany Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 23: Germany Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 24: Germany Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 25: France Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 26: France Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 27: France Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 28: Spain Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 29: Spain Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 30: Spain Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 31: Italy Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 32: Italy Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 33: Italy Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 34: Russia Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 35: Russia Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 36: Russia Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 37: Nordic Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 38: Nordic Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 39: Nordic Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 40: Benelux Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 41: Benelux Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 42: Benelux Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 43: Rest of Europe Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 44: Rest of Europe Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 45: Rest of Europe Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 46: APAC Myasthenia Gravis Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 48: APAC Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 49: APAC Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 50: China Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 51: China Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 52: China Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 53: Korea Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 54: Korea Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 55: Korea Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 56: Japan Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 57: Japan Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 58: Japan Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 59: India Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 60: India Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 61: India Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 62: Australia Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 63: Australia Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 64: Australia Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 65: Singapore Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 66: Singapore Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 67: Singapore Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 68: Taiwan Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 69: Taiwan Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 70: Taiwan Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 71: South East Asia Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 72: South East Asia Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 73: South East Asia Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 74: Rest of Asia-Pacific Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 75: Rest of Asia-Pacific Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 76: Rest of Asia-Pacific Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Myasthenia Gravis Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 78: Middle East and Africa Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 79: Middle East and Africa Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 80: Middle East and Africa Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 81: UAE Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 82: UAE Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 83: UAE Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 84: Turkey Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 85: Turkey Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 86: Turkey Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 87: Saudi Arabia Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 88: Saudi Arabia Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 89: Saudi Arabia Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 90: South Africa Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 91: South Africa Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 92: South Africa Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 93: Egypt Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 94: Egypt Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 95: Egypt Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 96: Nigeria Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 97: Nigeria Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 98: Nigeria Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 99: Rest of MEA Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 100: Rest of MEA Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 101: Rest of MEA Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 102: LATAM Myasthenia Gravis Treatment Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 103: LATAM Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 104: LATAM Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 105: LATAM Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 106: Brazil Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 107: Brazil Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 108: Brazil Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 109: Mexico Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 110: Mexico Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 111: Mexico Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 112: Argentina Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 113: Argentina Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 114: Argentina Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 115: Chile Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 116: Chile Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 117: Chile Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 118: Colombia Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 119: Colombia Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 120: Colombia Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 121: Rest of LATAM Myasthenia Gravis Treatment Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 122: Rest of LATAM Myasthenia Gravis Treatment Market Size and Forecast By Treatment - 2022-2034 (USD Billion)

Table 123: Rest of LATAM Myasthenia Gravis Treatment Market Size and Forecast By End-User - 2022-2034 (USD Billion)

We are featured on: